Skip to main content
Improve  Medical Instruments CO., Ltd. logo

Improve Medical Instruments CO., Ltd. — Investor Relations & Filings

Ticker · 300030 ISIN · CNE100000JL3 Shenzhen Stock Exchange Manufacturing
Filings indexed 1,954 across all filing types
Latest filing 2024-04-26 Management Reports
Country CN China
Listing Shenzhen Stock Exchange 300030

About Improve Medical Instruments CO., Ltd.

https://www.improve-medical.com

Improve Medical Instruments CO., Ltd. focuses on the development, production, and distribution of clinical laboratory and nursing solutions. The core product range includes evacuated blood collection systems, specimen collection and transport media, and laboratory automation equipment. The company also provides medical imaging components and point-of-care testing (POCT) systems. By integrating research and development with advanced manufacturing, the organization supports clinical diagnostics and patient care through high-precision tools designed for healthcare facilities and research laboratories. Its offerings are characterized by a commitment to diagnostic safety and efficiency across global markets.

Recent filings

Filing Released Lang Actions
2023年度总经理工作报告
Management Reports Classification · 95% confidence The document is titled '2023 年度总经理工作报告' which translates to '2023 Annual General Manager Work Report'. It contains detailed management commentary on the company's 2023 operational performance, financial data, R&D activities, marketing efforts, management system improvements, and plans for 2024. The content is a comprehensive management report discussing business trends, financial results, and outlook, typical of a Management Reports (MDA) filing. It is not a full annual report (10-K) as it lacks full financial statements and audit opinions, nor is it an earnings release or investor presentation. The length and detail confirm it is a substantive management report rather than a brief announcement or certification. Therefore, the appropriate classification is Management Reports (MDA).
2024-04-26 Chinese
公司章程 2024.04
Governance Information Classification · 95% confidence The document is titled as the "Company Articles of Association" (公司章程) of 阳普医疗科技股份有限公司 dated April 2024. It contains detailed provisions about the company's organizational structure, shareholder rights and obligations, share issuance and transfer, shareholder meetings, board and management roles, voting procedures, and other governance matters. There is no financial data, earnings information, audit results, or capital raising updates. The content is focused on the internal rules and governance framework of the company. This matches the definition of Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices. The document is lengthy (15,000 characters) and is the actual governance document, not an announcement or summary. Therefore, the appropriate classification is CGR with high confidence.
2024-04-26 Chinese
关于独立董事独立性情况的专项意见
Regulatory Filings Classification · 95% confidence The document is a short announcement (460 characters) from the board of 阳普医疗科技股份有限公司 regarding the independence of its independent directors. It references compliance with regulatory guidelines and confirms the independent status of directors. There is no financial data, no detailed report, and no mention of a meeting or voting results. The document is a regulatory compliance announcement related to governance but does not provide detailed governance structure or rules. It is not a full governance report (CGR) nor a management change announcement (MANG). Given its nature as a formal regulatory announcement about director independence, it best fits under Regulatory Filings (RNS).
2024-04-26 Chinese
审计委员会实施细则2024.04
Governance Information Classification · 95% confidence The document is titled as the implementation rules for the Audit Committee of a company, detailing the committee's composition, responsibilities, decision-making procedures, meeting rules, conflict of interest policies, and other governance-related provisions. It references relevant laws and company bylaws but does not contain any financial statements, audit opinions, or results of audits. It is a governance document outlining internal rules and structure related to audit oversight. Therefore, it fits best under Governance Information (CGR) rather than an audit report or annual report. The document length is 4146 characters, which is consistent with a detailed governance policy document rather than a brief announcement or a full financial report.
2024-04-26 Chinese
2023年度监事会工作报告
Management Reports Classification · 95% confidence The document is titled as the "2023年度监事会工作报告" which translates to "2023 Supervisory Board Work Report". It details the supervisory board's activities, meetings, oversight of financial and operational matters, internal controls, and audit opinions for the year 2023. It includes references to the annual report, audit opinions, and internal control evaluations, but it is itself a report from the supervisory board rather than the full annual report or audit report. The document is about the supervisory board's work and oversight, which aligns with a Management Reports category. It is not an announcement or a short notice, but a substantive report on supervisory activities and opinions for the year. Therefore, the best fitting category is Management Reports (MDA). The document length (3872 characters) is sufficient for a detailed report but not a full annual report, and the content is focused on supervisory board work rather than financial statements alone or audit details alone.
2024-04-26 Chinese
2023年度营业收入扣除情况的专项审核报告
Audit Report / Information Classification · 95% confidence The document is titled as a "专项审核报告" (Special Audit Report) on the deduction of operating revenue for the year 2023 by 阳普医疗科技股份有限公司. It is issued by a certified public accounting firm and includes detailed audit procedures and an audit opinion on the revenue deduction schedule. The document contains specific financial data related to revenue deductions and is a standalone audit report focusing on a particular aspect of the company's financials, not a full annual report or interim report. It is not a mere announcement or certification but an actual audit report with substantive financial information. Therefore, it fits the category of Audit Report / Information (AR). The document length is 2678 characters, which is consistent with a detailed audit report but not a full annual report. Hence, the classification is AR with high confidence. FY 2023
2024-04-26 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.